Target Price | $4.00 |
Price | $0.66 |
Potential |
506.15%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a PAVmed, Inc. price target 2026.
The average PAVmed, Inc. target price is $4.00.
This is
506.15%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend PAVmed, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the PAVmed, Inc. stock has an average upside potential 2026 of
506.15%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 3.00 | 0.21 |
22.45% | 93.17% | |
Net Margin | 186.67% | -3,114.15% |
104.46% | 1,768.29% |
1 Analyst has issued a sales forecast PAVmed, Inc. 2025 . The average PAVmed, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast PAVmed, Inc. 2025 . The average PAVmed, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.50 | -0.57 |
105.46% | 214.00% | |
P/E | negative | |
EV/Sales | 197.71 |
1 Analysts have issued a PAVmed, Inc. forecast for earnings per share. The average PAVmed, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Ascendiant Capital |
Locked
➜
Locked
|
Locked | Dec 09 2024 |
Ascendiant Capital |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
Analyst Rating | Date |
---|---|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Dec 09 2024 |
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Sep 10 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.